Chronic Insomnia: Clinical Trials

10 trials for Chronic Insomnia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 2 unknown, 1 recruiting, 1 terminated. 10 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 410Completed 6, Unknown 2, Recruiting 1, Terminated 1

Follow Chronic Insomnia: new trials by email Literature Review of Chronic Insomnia trials Research Report on Chronic Insomnia

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A SMART Approach to Evaluating the Benefits of Common Prescription and OTC Medications for Insomnia
Sleep Hygiene Education, Melatonin IR, 3 mg, Melatonin IR, 5 mg - Insomnia, Insomnia Disorder
Phase 4RecruitingUniversity of Pennsylvania12002026-05-012026-09-16
CBT-I or Zolpidem/Trazodone for Insomnia
Zolpidem, Internet Cognitive Behavioral Therapy for Insomnia (CBT-I), Trazodone - Chronic Insomnia
Phase 4CompletedCalifornia Pacific Medical Center Research Institute1552022-02-252025-02-24
Xuefu-Zhuyu Capsule for the Treatment of "Qizhi Xueyu Zheng" (Qi Stagnation and Blood Stasis Syndrome)
Xuefu-Zhuyu Capsule, placebo, conventional therapy - Chinese Medicine, Stable Coronary Heart Disease
Phase 4UnknownZhong Wang7202019-12-312022-11-15
Impact of Suvorexant on Sympathetic Nerve Activity and Baroreflex Function in Chronic Insomnia
Suvorexant, Placebo - Chronic Insomnia
Phase 4UnknownMontana State University342019-04-182021-10-07
The Study of Combination Use of Melatonin Receptor Agonist for Dose Reduction or Interruptions of Benzodiazepine (BZD) and Non-BZD Hypnotics on Chronic Insomnia
Ramelteon 8mg, Placebo - Chronic Insomnia
Phase 4CompletedTranslational Research Center for Medical Innovation, Kobe, Hyogo, Japan172018-02-062024-11-20
Safety and Efficacy of Chronic Hypnotic Use 2
placebo, Zolpidem CR, Eszopiclone - Chronic Insomnia
Phase 4CompletedHenry Ford Health System412015-08-052024-03-29
Cognitive-Behavior Therapy for Insomnia
Cognitive-Behavior Therapy, Behavior Therapy, Cognitive Therapy - Chronic Insomnia
Phase 4CompletedLaval University1862008-04-012013-07-02
Facilitation of Zolpidem (≥10 mg) Discontinuation Through Use of Ramelteon in Subjects With Chronic Insomnia
Ramelteon and zolpidem, Placebo and zolpidem - Chronic Insomnia
Phase 4CompletedTakeda1352007-04-012010-07-20
Subjective Efficacy of Ramelteon on Sleep in Adults With Chronic Insomnia.
Ramelteon, Placebo - Chronic Insomnia
Phase 4CompletedTakeda5522006-10-012016-06-28
Treating Chronic Insomnia in Breast Cancer Patients
Placebo, Ramelteon - Chronic Insomnia
Phase 4TerminatedAccelerated Community Oncology Research Network162006-08-012011-08-22

Narrower conditions

Sleep Initiation and Maintenance Disorders (10)  ·  Endometriosis (1)  ·  Headache (1)  ·  Parasomnias (1)  ·  Sleep Wake Disorders (1)

Broader conditions

Dyssomnias (10)  ·  Mental Disorders (10)  ·  Nervous System Diseases (10)  ·  Sleep Disorders, Intrinsic (10)  ·  Sleep Wake Disorders (9)  ·  Neurologic Manifestations (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Female (1)  ·  Pain (1)  ·  Urogenital Diseases (1)

Interventions

ramelteon (4)  ·  Zolpidem (3)  ·  Trazodone (2)  ·  Behavior Therapy (1)  ·  Cognitive Behavioral Therapy (1)  ·  Diphenhydramine (1)  ·  Doxepin (1)  ·  Eszopiclone (1)  ·  Xue-Fu-Zhu-Yu decoction (1)  ·  suvorexant (1)

Sponsors

Takeda (2)  ·  Accelerated Community Oncology Research Network (1)  ·  California Pacific Medical Center Research Institute (1)  ·  Henry Ford Health System (1)  ·  Laval University (1)  ·  Montana State University (1)  ·  Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan (1)  ·  University of Pennsylvania (1)  ·  Zhong Wang (1)

Countries

United States (8)  ·  Canada (1)  ·  China (1)  ·  Japan (1)

Top investigators

Charles M. Morin, PhD (1)  ·  Daniel J. Buysse, MD (1)  ·  Edward J. Stepanski, Ph.D. (1)  ·  Jason Carter, PhD (1)  ·  Katie L. Stone, PhD (1)  ·  Michael L Perlis, PhD (1)  ·  Qing-Quan Liu, Prof. (1)  ·  Timothy A Roehrs, PhD (1)  ·  Yuichi Inoue, MD, Ph.D. (1)  ·  Zhong Wang, M.D. (1)

Results publications

PMID 26763501, PMID 26963600, PMID 29265834, PMID 36821333